These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Autocrine growth mechanisms of cholesteatoma epithelium]. Schilling V, Holly A, Bujía J, Schulz P. Laryngorhinootologie; 1993 Jul; 72(7):319-23. PubMed ID: 8369082 [Abstract] [Full Text] [Related]
6. Pathology of the ossicular chain in various chronic middle ear diseases. Tos M. J Laryngol Otol; 1979 Aug; 93(8):769-80. PubMed ID: 490029 [Abstract] [Full Text] [Related]
7. [Expression of 4F2-activation antigen in middle ear cholesteatoma]. Holly A, Bujía J, Sanchez-Madrid F. Laryngorhinootologie; 1993 Jul; 72(7):324-7. PubMed ID: 8369083 [Abstract] [Full Text] [Related]
10. The nature of the epithelium in acquired cholesteatoma. Lee RJ, Mackenzie IC, Hall BK, Gantz BJ. Clin Otolaryngol Allied Sci; 1991 Apr; 16(2):168-73. PubMed ID: 1712679 [Abstract] [Full Text] [Related]
11. Aural polyps as predictors of underlying cholesteatoma. Milroy CM, Slack RW, Maw AR, Bradfield JW. J Clin Pathol; 1989 May; 42(5):460-5. PubMed ID: 2732339 [Abstract] [Full Text] [Related]
12. Possible role of interleukin 1 alpha and interleukin 1 beta in the pathogenesis of cholesteatoma of the middle ear. Schilling V, Negri B, Bujía J, Schulz P, Kastenbauer E. Am J Otol; 1992 Jul; 13(4):350-5. PubMed ID: 1384343 [Abstract] [Full Text] [Related]
13. Junctions of squamous epithelium with middle ear mucosa. Palva T, Lehto VP, Virtanen I, Mäkinen J. Acta Otolaryngol; 1985 Jul; 99(3-4):297-304. PubMed ID: 2409738 [Abstract] [Full Text] [Related]